Evogene Strategic Asset Allocation Index
Evogene strategic asset allocation index. Evogene (EVGN) has a Strategic Asset Allocation Index of 0.0% as of September 2025. Strategic assets (PP&E of ILA- plus long-term investments of ILA0.00) total ILA0.00, measured against net assets of ILA17.25 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See EVGN equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Evogene (2006–2024)
Strategic asset allocation index of Evogene from 2006 to 2024. This chart shows how Evogene's Strategic Asset Allocation Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 0.0%, representing strategic assets of ILA0.00 against net assets of ILA17.25 Million ILA. Check Evogene tangible equity quality to evaluate the tangible quality of the company's equity base.
Evogene Strategic Asset Allocation Index by Year (2006–2024)
Evogene strategic asset allocation index by year from 2006 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Evogene from 2006 to 2024, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see EVGN market cap overview.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.6% | ILA82.00K | ILA- | ILA82.00K | ILA14.84 Million | ▲ +0.6 pp |
| 2023 | 0.0% | ILA0.00 | ILA- | ILA0.00 | ILA28.68 Million | ▼ -11.7 pp |
| 2022 | 11.7% | ILA4.07 Million | ILA4.07 Million | ILA- | ILA34.79 Million | ▲ +5.1 pp |
| 2021 | 6.6% | ILA4.18 Million | ILA4.18 Million | ILA- | ILA63.42 Million | ▼ -0.3 pp |
| 2020 | 6.9% | ILA3.94 Million | ILA3.94 Million | ILA- | ILA56.88 Million | ▼ -1.8 pp |
| 2019 | 8.7% | ILA5.25 Million | ILA5.25 Million | ILA- | ILA60.22 Million | ▲ +2.4 pp |
| 2018 | 6.3% | ILA3.19 Million | ILA3.19 Million | ILA- | ILA50.31 Million | ▼ -0.6 pp |
| 2017 | 6.9% | ILA4.79 Million | ILA4.79 Million | ILA- | ILA69.38 Million | ▼ -0.5 pp |
| 2016 | 7.4% | ILA6.48 Million | ILA6.48 Million | ILA- | ILA87.29 Million | ▼ -0.5 pp |
| 2015 | 7.9% | ILA8.20 Million | ILA8.20 Million | ILA- | ILA103.75 Million | ▼ 0.0 pp |
| 2014 | 7.9% | ILA9.19 Million | ILA8.81 Million | ILA382.00K | ILA116.08 Million | ▲ +1.8 pp |
| 2013 | 6.2% | ILA7.69 Million | ILA7.21 Million | ILA471.00K | ILA124.75 Million | ▼ -9.2 pp |
| 2012 | 15.3% | ILA7.40 Million | ILA7.40 Million | ILA- | ILA48.26 Million | ▲ +0.5 pp |
| 2011 | 14.8% | ILA7.14 Million | ILA7.14 Million | ILA- | ILA48.09 Million | ▼ -9.8 pp |
| 2010 | 24.6% | ILA4.12 Million | ILA4.12 Million | ILA- | ILA16.73 Million | ▲ +6.8 pp |
| 2009 | 17.8% | ILA3.44 Million | ILA3.44 Million | ILA- | ILA19.34 Million | ▲ +3.6 pp |
| 2008 | 14.1% | ILA1.36 Million | ILA1.36 Million | ILA- | ILA9.61 Million | ▲ +1.1 pp |
| 2007 | 13.0% | ILA742.00K | ILA742.00K | ILA- | ILA5.71 Million | ▲ +2.7 pp |
| 2006 | 10.3% | ILA1.69 Million | ILA1.69 Million | ILA- | ILA16.36 Million | — |